Andexanet alfa for the reversal of Factor Xa inhibitor related anticoagulation

Practice Guidelines for Perioperative Blood Management

(2015) &NA;   ANESTHESIOLOGY

Antidotes for Novel Oral Anticoagulants

(2015) Mark Crowther et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Idarucizumab for Dabigatran Reversal

(2015) Charles V. Pollack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity

(2015) Deborah M. Siegal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

(2014) J. Beyer-Westendorf et al.   BLOOD

Late-Breaking Clinical Trial Abstracts

(2014)   CIRCULATION

PRT064445 reverses rivaroxaban induced anticoagulation in a rabbit liver laceration "treatment" model

(2014) S. Hollenbach et al.   EUROPEAN HEART JOURNAL

Direct Oral Anticoagulants

(2014) Jerrold H. Levy et al.   JACC-Cardiovascular Interventions

Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers

(2014) M. Levi et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Use of PER977 to Reverse the Anticoagulant Effect of Edoxaban

(2014) Jack E. Ansell et al.   NEW ENGLAND JOURNAL OF MEDICINE

A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa

(2013) Genmin Lu et al.   NATURE MEDICINE

Evidence-Based Management of Anticoagulant Therapy

(2012) Anne Holbrook et al.   CHEST

Reversal of drug-induced anticoagulation: old solutions and new problems

(2012) Walter “Sunny” Dzik   TRANSFUSION

2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines

(2011) Victor A. Ferraris et al.   ANNALS OF THORACIC SURGERY

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

(2010) Lewis B. Morgenstern et al.   STROKE

French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding)

(2010) Gilles Pernod et al.   THROMBOSIS RESEARCH